Main menu

You are here

Treatments

FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

Fri, 2022-08-19 16:38 — mike kraft

FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound The U.S. Food and Drug Administration (FDA) has ordered Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
Log in or register to post comments

U.S. Covid costs for vaccines and treatment to shift to patients and insurers

Fri, 2022-08-19 13:19 — mike kraft

COVID costs could fall on insurers and consumers HHS has a meeting scheduled later this month with drugmakers, pharmacies, and state health departments to address the changes. Arielle Dreher Axios

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. Covid costs for vaccines and treatment to shift to patients and insurers
Log in or register to post comments

How to assess risk for long term Covid issues--CNN

Fri, 2022-08-19 09:56 — mike kraft

Long Covid risk extends two years after infection. Here's how to assess your risk A new study found an increased risk of certain long Covid-19 symptoms up to two years after an original infection. Sandee LaMotte, CNN CNN

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about How to assess risk for long term Covid issues--CNN
Log in or register to post comments

Pages

Page loaded in 0.486 seconds.